KTD-092

CAT: 0804-HY-173615Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-173615Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
KTD-092 is a hit for DYRK1A inhibition, with an IC50 of 22 nM for human DYRK1A. KTD-092 can be used in the research for Down syndrome (DS), Alzheimer's disease (AD), autism spectrum disorder (ASD), diabetes and other neurodegenerative diseases[1].
UNSPSC
12352005
Target
DYRK
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease; Neurological Disease
Smiles
CCN1C=NN=C1C2=NC(NC(C3=CC(OC)=C(C=C3OC)OC)=O)=CC=C2
Molecular Formula
C19H21N5O4
Molecular Weight
383.40
References & Citations
[1]Sujeong Hong, et al. Discovery of 2- (1,2,4-triazol-3-yl) pyridine KTD-092 as a novel DYRK1A. Wiley Online Library inhibitor. 2025.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
DYRK1

Related Products

CatalogName
HY-111484-01GDC-0927
HY-145384-01ROC-0929
HY-19394CLX-0921
HY-161982-01JNU-0921
HY-173459N-0920
HY-120207-01(R) -GDC-0927
HY-19394A-01(E) -CLX-0921
HY-111484AGDC-0927 (Racemate)

Alternative Products

CatalogName
T210988-01KTD-092
MBS131494ARQ-092
A16286-10ARQ-092 10mg
A16286-5ARQ-092 5mg
MBS3841548-01ARQ-092 (Miransertib)
C12232-01Miransertib (ARQ-092)
A16286-50ARQ-092 50mg
C13354-01Miransertib (ARQ 092) HCl
A16286-1ARQ-092 (Miransertib) 1mg
A16286-25ARQ-092 (Miransertib) 25mg

Popular Products